Site-specific mutation was demonstrated in a shuttle vector system using nitrogen mustard-conjugated oligodeoxyribonucleotides (ODNs). Plasmid DNA was modified in vitro by ODNs containing all four DNA bases in the presence of Escherichia coli RecA protein. Up to 50% of plasmid molecules were alkylated in the targeted region of the supF gene and mutations resulted upon replication in mammalian cells. ODNs conjugated with either two chlorambucil moieties or a novel tetrafunctional mustard caused interstrand crosslinks in the target DNA and were more mutagenic than ODNs that caused only monoadducts.
INTRODUCTION
The human genome project will identify thousands of new genes in the next few years, and the next great endeavor will be to elucidate functions of these novel genes. One approach to gene function is to isolate and characterize mutant cells that contain dysfunctional alleles of the gene in question. This approach will require an efficient method for targeted gene disruption in living cells. Practicable site-directed mutagenesis may also have applications in gene therapy and in genetic engineering of agriculturally significant plants and animals.
One developing technology for targeted mutagenesis is the use of gene modifying oligonucleotides (GMOs). GMOs are oligodeoxyribonucleotides (ODNs) that contain reactive groups capable of covalently modifying target DNA. Conceptually, sitedirected mutation by reactive GMOs requires at least three events: (i) recognition of the target sequence by the ODN, (ii) DNA modification (adduct, crosslink, cleavage) and (iii) fixation of a mutation via action of DNA repair and/or replication mechanisms. Alkylating ODNs can be directed to single-stranded DNA targets using Watson-Crick base pairing rules (1) . Double-stranded DNA (dsDNA) can be targeted by ODNs that form Hoogsteen (or reverse-Hoogsteen) base pairs with a duplex target, resulting in a triplex (2) . Alternatively, dsDNA can be targeted with recombinase-assisted ODNs (3) . Association of a GMO with the target DNA sequence brings the modifying agent (covalently linked to the ODN) into close proximity of the targeted base(s).
A variety of reactive groups capable of covalently modifying DNA have been attached to ODNs and characterized in vitro (2, (4) (5) (6) (7) (8) (9) (10) . To date only psoralen-conjugated triplex forming ODNs (11) (12) (13) and unmodified triplex forming ODNs (14) , have been reported to have mutagenic capability in mammalian cells. A major limitation to the widespread application of triplex forming ODNs is the requirement of long homopurine runs for triplex formation.
Previously, we described a new class of GMOs that contain all four DNA bases and a labile reactive group (3, 15) . These GMOs interact with homologous sequences in the presence of Escherichia coli RecA protein. When ODN is complexed with RecA in the presence of ATPγS, (non-hydrolyzable cofactor analog), the resultant nucleoprotein filament is able to search for homologous sequences in dsDNA and form a stable synaptic complex with it (16) (17) (18) . This RecA-stabilized threestranded complex undergoes strand exchange, resulting in a 'D-loop'-like structure where the incoming ODN appears to be Watson-Crick hydrogen bonded to the complementary strand of the target dsDNA (3, 19, 20) . Thus an alkylating agent conjugated to the ODN is brought into close proximity to bases in the target DNA, enabling sequence specific alkylation (Fig. 1) . We recently showed sequence-specific alkylation in genomic DNA using this method (21) .
To study the mutagenic capability of these GMOs, we chose a shuttle vector system containing the supF gene as the target DNA sequence (22) . Reactions of alkylating GMOs with plasmid DNA were performed in vitro, and mutations were fixed by replication of the modified plasmid DNA in mammalian cells. Crosslinks caused by the GMOs were characterized and the sites of alkylation were correlated with sites of point mutations.
MATERIALS AND METHODS

Synthesis of GMOs
ODNs were prepared on an Applied Biosystems Model 394 synthesizer (1 µmol scale). The 5′-terminus of each ODN was blocked by addition of a propanol phosphate group to prevent 32 P labeling during the alkylation assay. This blocking group was introduced using Spacer Phosphoramidite C3 (Glen Research, ii Sterling, VA). One or two 5-(3-aminopropyl) uridine linker groups were introduced into the ODNs as shown in Figure 2A through the use of the appropriate phosphoramidite (23) . Preparative HPLC purification, detritylation and butanol precipitation of the oligos was performed by standard methods. Post-synthetic modification of the aminopropyl-dU linkers was accomplished by treating a DMSO solution of the ODN with activated ester derivatives of either a bifunctional mustard (chlorambucil) or a tetrafunctional mustard as shown in Figure 2B . The conjugation chemistry using bifunctional mustards was described earlier for standard 5′-modified triplex forming ODNs (24) . Synthesis and chemical properties of the tetrafunctional mustard will be described in a separate paper. The desired GMO was isolated as a single peak during HPLC purification and concentrated and precipitated as described earlier (24) . The bis-conjugate (GMO3) was identified by longer retention time on HPLC (a mixture of mono-conjugates was also observed). The pellet was dried in vacuo for 15 min and the purified product was dissolved in ice cold water. An aliquot was removed for C 18 HPLC analysis and another aliquot was removed for concentration determination. The bulk solution was immediately stored at -70°C for future use. HPLC analysis showed >90% purity.
Cell lines/bacteria strains/plasmid DNA HEK293 cells (ATCC, Rockville, MD) were cultured in DMEM supplemented with 10% fetal bovine serum, 2mM L-glutamine and antibiotics (Gibco). Plasmid pSP189 (25) and E.coli strain MBM7070 were kindly provided by Dan Levy (NIH, Bethesda, MD). Briefly, this plasmid contains an 8-bp signature sequence immediately adjacent to the supF gene, the pBR327 ori and ApR gene for replication and selection in E.coli, and the SV40 ori and T antigen for replication in mammalian cells. Plasmid DNA used in alkylation reactions was propagated in MBM7070, isolated by alkaline lysis (26) and purified by CsCl/ethidium bromide banding (27) .
RecA assisted alkylation of plasmid DNA
The standard reaction conditions are described (3). Briefly, 3 µg of pSP189 DNA were added (10 nM final concentration) iii to a presynaptic complex formed in 100 µl of 10 mM Tris-acetate buffer (pH 7.5), containing 50 mM sodium acetate, 12 mM magnesium acetate, 1 mM DTT, 1 mM ATPγS and 5% glycerol, using 100 nM reactive ODN and 2 µM RecA protein (New England Biolabs) in an ice/water bath. Samples were transferred to a 37°C water bath and incubated for 6 h (over five half-lives for ionization of the first 2-chloroethylamino group of chlorambucil). After the reaction, products were deproteinized for 30 min at 37°C in 200 µg/ml proteinase K, 0.5% SDS; phenol/ chloroform extracted and ethanol precipitated. In most cases, reaction products were then aliquoted for both quantification of alkylation and transfections (mutation screens).
Assays for alkylation
The efficiency of alkylation on individual strands of the target region was assayed in the following manner. Reaction products were restricted with either EcoRI or MluI in 50 µl according to manufacturer's protocols (New England Biolabs). Linear plasmid molecules were 5′ dephosphorylated by incubation with 5 U calf intestinal phosphatase (NEB) at 37°C for 30 min. Samples were diluted 3-fold in TE, supplemented with EDTA to 5 mM final concentration, extracted with phenol/chloroform and ethanol precipitated. To 32 P label the 5′ ends of the plasmid DNA, pellets were dissolved in 50 µl buffer for T4 polynucleotide kinase (NEB) containing 20 µCi of [γ-32 P]ATP and 1 U of T4 polynucleotide kinase and incubated for 30 min at 37°C. Samples were diluted as above, phenol/chloroform extracted and ethanol precipitated. DNA pellets were dissolved in the appropriate restriction buffer and digested (MluI or EcoRI) to produce two EcoRI/MluI fragments: a 160 bp fragment including the supF gene and a 4.8 kb vector fragment. After ethanol precipitation, DNA pellets were washed with 70% ethanol, dried and dissolved in 80% formamide containing 0.1% xylene cyanol and bromophenol blue. DNA fragments and alkylation products were separated by 4% denaturing PAGE. The gel was dried and analyzed by autoradiography (Kodak AR film) and phosphorimagery (Bio-Rad). The level of alkylation was determined as the percentage of a 160 nt fragment with a reduced electrophoretic mobility due to the monoadduct or interstrand crosslink.
To precisely determine the sites of alkylation, a 210 bp amplicon (covering the region 4889-146 of pSP189) was generated using the primers 5′-GCGACACGGAAATGTTG-AATACT and 5′-CTTTCGCTAAGGATCCGGGTAC. The targeted sequence for all reactive ODNs was located in the middle of this amplicon. Amplicon was 5′ 32 P end labeled on either the sense or antisense strand (3), then subjected to RecA assisted alkylation using the same conditions as for plasmid DNA. After deproteinization and phenol/chloroform extraction, ethanol precipitated samples were treated with 10% piperidine for 30 min at 95°C. Samples were dried, resuspended in 100 µl of 0.3 M NaOAc and precipitated with ethanol. DNA was recovered by centrifugation and pellets were washed with 70% ethanol. Dried pellets were dissolved in denaturing loading dye solution and subjected to PAGE as above. An A+G sequencing ladder (28) was loaded adjacent to the samples so that cleavage sites could be precisely mapped. The degree of alkylation at particular sites was estimated from the relative intensities of bands.
Mutational analyses
HEK293 cells were transfected with modified plasmid DNA using DOTAP (Boehringer Mannheim). Twenty-four hours prior to transfection, 3 × 10 5 cells were plated per well in 6-well trays. For each well, 3 µg plasmid DNA and 15 µg DOTAP were mixed and applied to cells according to the manufacturer's protocol. Cells were harvested by scraping 48 h after transfection and plasmid DNA was prepared (29) . DNA samples were digested with DpnI to select for plasmid molecules that replicated in mammalian cells (30) . An E.coli strain (MBM7070) carrying an amber mutation in the lacZ gene (lacZamCA7020) was transformed with plasmid DNA by electroporation (Bio-Rad). Transformants were selected on indicator medium [LB agar containing X-Gal and IPTG (Sigma)] and colonies were scored for blue or white color. White colonies were picked and streaked on indicator medium to verify the lacZ -phenotype. Liquid cultures of lacZ -clones were grown, plasmid DNA prepared and the supF gene was sequenced by the dideoxy/ chain termination method. The entire supF coding region and the adjacent signature sequence of pSP189 was read from a single sequencing reaction using the primer 5′-GCGACACG-GAAATGTTGAATACT-3′ and T7 Sequenase Quick-Denature plasmid sequencing kit (Amersham Life Science).
RESULTS
GMO design
We developed a new class of GMOs that contain all four standard deoxyribonucleotide bases (see Introduction and Fig. 1) . A series of GMOs was designed to target sequences in the supF gene that would be substrates for the alkylating agents (Fig. 2) . Individual 30mers were complementary to one strand of the coding region of supF. Alkylating agents (chlorambucil or tetrafunctional mustard), conjugated to an internal base (dU) of the GMO via a 5-propylamine linker, were generally positioned 5′ to C residues so that the agents could interact with G residues of the complementary DNA. Mustards such as chlorambucil are known to alkylate the N7 position of guanine in the major groove of duplex DNA (31) . For example, the group of three guanines [36] [37] [38] on the antisense strand are an ideal target for the mustard moiety conjugated at the U corresponding to T35 in GMO2, GMO3 and GMO4. Point mutations at the target sites chosen (e.g. G36), are known to cause phenotypic changes in supF (22) .
GMOs alkylated dsDNA in vitro
GMOs were characterized first for their ability to alkylate target DNA. Reactions of GMOs with plasmid target sequences were carried out in the presence of RecA protein. To quantify reaction products, samples were processed as described in Materials and Methods. A gel from a typical experiment is shown in Figure 3 . Upon electrophoresis, modified DNA species migrate more slowly than the denatured 160 nt restriction fragment. Species consisting of an ODN joined to a single strand of the targeted restriction fragment by a single alkylation event are referred to hereafter as monoadducts. Interstrand crosslinks tether the ODN to both strands of the 160 bp fragment, therefore such products are expected to migrate as if greater than 320 nt. Consistent with this expectation, several species were observed that migrated slightly faster than e38 Nucleic Acids Research, 1999, Vol. 27, No. 24 iv a 401 nt product that resulted from EcoRI* activity (Fig. 3,  lanes 1-5) . No modified species were observed in lanes derived from no GMO (Fig. 3, lanes 1 and 6) and GMO3 without RecA (Fig. 3, lanes 2 and 7) controls. A GMO that was conjugated with chlorambucil at two sites, GMO3, reacted individually with both strands (~15% monoadducts on each strand) and produced a significant amount (7.8% of the plasmid molecules) of interstrand crosslinks. In contrast, GMO2 (containing a single chlorambucil) produced relatively few interstrand crosslinks (0.7%), despite efficient monoadduct formation on each strand. The GMO containing the novel tetrafunctional mustard (GMO4) produced interstrand crosslinks almost as efficiently as GMO3. GMO1 reacted inefficiently with the MluI-labeled strand (6.2% monoadducts). This was expected since the complementary strand has no guanine residues near base 29. However, 21% of the homologous (outgoing strand in the D-loop) strands were alkylated. The observations described here were reproducible. Average values resulting from several experiments are presented in Table 1 .
Site-specific modification of the supF gene
To precisely determine the nucleotide positions of adducts, a cleavage assay was performed. This assay is similar to the alkylation assay, except that samples are treated with piperidine prior to gel electrophoresis. Guanines alkylated at the N7 position are cleaved under the experimental conditions (28, 32) . A control DNA fragment is subjected to Maxam-Gilbert sequencing reactions and loaded on the gel adjacent to the samples, so that the sites of cleavage in the samples can be mapped. Results of experiments where the DNA target was a 210 bp amplicon (instead of the entire pSP189 plasmid) are represented in Figure 4 . In general, alkylation was detected (cleavage occurred) at a guanine (G) that was complementary to the base 3′ to the conjugation site. With GMO2, GMO3 and GMO4, the predominant site of alkylation was G36 on the complementary (antisense) strand. G37 and G38 on the complementary strand, as well as several G residues on the homologous (outgoing) strand were alkylated much less. Chlorambucil at the site homologous to T29 in GMO1 and GMO3 alkylated Gs (25,27,28,30-33) on the outgoing (homologous) strand. In experiments with all four GMOs (GMO4 most noteworthy), some uncleavable products were observed on the homologous strand (data not shown).
Alkylating GMOs cause mutations in supF
Modified plasmid DNA was introduced into and replicated in mammalian cells, rescued, and assayed for mutation in E.coli. The supF tRNA suppresses an amber mutation in the lacZ gene of the host E.coli strain, resulting in a β-galactosidase positive Table 2 . Sham controls (no GMO or GMO without RecA protein) typically yielded white colonies at frequencies of 0.1-0.2%. Reactive ODNs (in the presence of RecA protein) that contained two chlorambucils (GMO3) or a tetrafunctional mustard (GMO4) produced the highest mutation frequencies (up to~2%). GMOs containing a single chlorambucil (GMO1, GMO2) produced mutation frequencies just slightly above background. 
DNA sequencing reveals targeted mutations
Plasmid DNA was prepared from mutant clones and the supF alleles were sequenced. The most common mutations were single base substitutions near the sites targeted by the GMOs. For example, in 23 of 42 clones (55%) resulting from GMO3 treatment, a single base substitution occurred at nucleotides 36-38 (Fig. 5C ). Mutations were not found adjacent to base 29 in experiments with GMO1 and GMO3. While most mutant clones derived from GMO-treated samples contained single base substitutions, some clones contained two base substitutions, for example, C→T and G→A at positions 36 and 39, respectively, in a GMO3-derived clone (depicted above the solid horizontal line in Fig. 5C ). Only deletions were observed in the supF region of five mutant clones derived from sham control samples (no GMO, data not shown). In another class of controls, involving GMO3 without RecA, four deletions and two dispersed point mutations were observed (not shown). Deletions, rearrangements and dispersed point mutations were also observed in GMO-treated samples (Fig. 5A-D) .
DISCUSSION
We report a significant advance in the development of reagents for targeted mutagenesis of DNA in mammalian cells. We characterized reaction products of GMOs containing chlorambucil or a novel tetrafunctional mustard and demonstrated targeted mutagenesis. The DNA adducts that resulted from GMO treatments were novel. Nitrogen mustards induced alkylation at guanines, and probably at other sites, resulting in covalent attachment of an ODN to the target DNA. Very little is known about the repair of ODN-directed DNA damage in mammalian cells.
In experiments with GMO3, where~50% of the plasmid molecules were alkylated,~2% of the recovered plasmids contained mutations in the supF gene. Correcting for incomplete modification,~4% (2%/0.5) of alkylated plasmid molecules mutated. This value might be artificially low. First, alkylated plasmid molecules might have been at a selective disadvantage for replication in the host mammalian cells. Previous observations support this notion: (i) psoralen-induced interstrand crosslinks reduced transformation frequencies of plasmids (33), (ii) damaged DNA strands replicated less efficiently than undamaged strands of plasmids (34, 35) and (iii) apurinic sites obstructed DNA polymerases in vitro (36) . Second, monoadducts may have been efficiently repaired in HEK293 cells while interstrand crosslinks (or possibly intrastrand crosslinks, or multiple monoadducts) were highly mutagenic. If we correct for the frequency of interstrand crosslinks (~8% of the plasmid molecules contained interstrand crosslinks in GMO3 treated samples), the resulting mutation frequency would increase tõ 25% (2%/0.08). Others have noted efficient repair of guanine monoadducts. N7-methylguanine is not highly mutagenic when directly incorporated into DNA (37) , and this monoadduct is efficiently repaired in mammalian cells (38, 39) .
It appeared that interstrand crosslinks correlated with relatively high mutation rates. First, the tetrafunctional mustard was more mutagenic than the bifunctional chlorambucil when conjugated at position 35 (GMO4 versus GMO2). Second, a GMO containing two chlorambucils (GMO3) was much more mutagenic than GMOs with only one chlorambucil (GMO1 and GMO2). Similar observations were made in experiments involving another set of GMOs targeted to a different region of supF (data not shown). In previous studies involving psoralenconjugated triplex forming ODNs, (12) , interstrand thyminethymine crosslinks were much more mutagenic than monoadducts. Interestingly, we did not detect mutations near position 29 using GMO3, but the frequency of mutations recovered near position 35 was apparently stimulated by the chlorambucil at position 29. This can be partially explained, since an interstrand crosslink would result from (observed) alkylation of guanines on the sense strand near position 29 and on the antisense strand near position 35. Why mutations were observed near position 35, but absent near position 29, is unclear.
While the N7 of guanine is the predominant target, it should be noted that other nucleophilic sites in DNA can be alkylated by nitrogen mustards. For example, chlorambucil modified the N3 positions of adenine and inhibited transcription in vitro (40) . Cytidine can also be attacked by such mustards (41) . The products of alkylation at these sites can not be cleaved (mapped) under the conditions we used. Uncleavable products resulted from all four GMOs, albeit at far lower levels than the cleavable products of alkylation at guanines. We cannot exclude the possibility that the uncleavable products were mutagenic. In their review, Povirk and Shuker (42) noted that no single type of lesion can be implicated as primarily responsible for mustard-induced mutagenesis. In different biological systems, different adducts appeared to be mutagenic.
In general, site-specific alkylation led to site-specific mutation. Point mutations were typically observed at the most modified sites (the guanine complementary to the base 3′ of the mustard conjugation site). Thus we demonstrate targeted mutagenesis using alkylating GMOs. Some mutations, however, were found at less modified sites. For example, efficient modification and mutation occurred at position 36 in GMO3-and GMO4-treated samples, but the adjacent site (position 37) was often mutated despite relatively low alkylation. In experiments with psoralenconjugated triplex forming ODNs, (11, 12) mutations occurred adjacent to the crosslinked sites. The subtle incongruity of alkylation and mutation positions probably reflects DNA repair mechanisms. Efficiency of repair may depend upon local sequence context (43) . Also, repair of an interstrand crosslink was initiated by excision of an~25 nt undamaged strand adjacent to, not including, the crosslinked site (44) . Other DNA-damaging agents might produce more specific mutagenesis than the mustards described here.
Dispersed point mutations, deletions and rearrangements were predominant in 'no GMO' and 'no RecA' controls, and such mutations were also observed in GMO-treated samples. High frequency rearrangements were reported in early experiments with shuttle vectors (45, 46) . Rearrangements and deletions in controls are presumably attributable to nicked plasmid DNA.
In support of this notion, heteroduplex plasmids were more mutation prone than completely double-stranded plasmids (35) . Since our experimental mutation frequencies were typically <10-fold above the background frequency, it is not surprising that we observed some deletions etc. dispersed along the supF gene in GMO-treated samples. We cannot rule out, however, that some of the observed rearrangements, deletions and dispersed point mutations were caused by GMOs.
The GMOs we describe here differ from those described in other reports in several respects. First, we used four-letter ODNs that offer much greater flexibility and sequence specificity than triplex forming ODNs (47) and polyamides (48) . Four-letter GMOs could be designed to target virtually any sequence. Four-letter 30mers, as described here, are sufficiently complex to insure target specificity in the human genome (3 × 10 9 bp) since there are 1.1 × 10 18 possible 30mers. Triplex forming ODNs require homopurine runs, which are rare in the genome and are rarely longer than 12 bases in coding regions (further discussion in 21). Polyamides utilize a degenerate three-letter code, and therefore have lower specificity than nucleotide-based systems. Second, the mustards employed here react spontaneously with DNA, in contrast to the UV-activated psoralens (12, 47) . Also, we conjugated the alkylating agents to internal bases, instead of to terminal bases. This might reduce the incidence of non-specific alkylation events, since the agent is expected to be sterically hindered by the ODN and RecA protein. Finally, the potential targets for GMO strategies is hereby increased since nitrogen mustards attack guanine predominantly, in contrast to psoralen which attacks thymine.
Reactive RecA assisted ODNs could be useful in a variety of research and diagnostic applications. We have previously demonstrated gene specific alkylation in naked genomic DNA (21) . This raises the possibility that RecA assisted GMOs could be used for affinity capture of rare sequences in complex mixtures. By performing a cleavage reaction after alkylation of both DNA strands, these GMOs could function as highly specific synthetic restriction enzymes. Several challenges remain that must be addressed before this technology can be used for mutation of endogenous genes. They include: (i) proper delivery of the GMO and RecA (or other recombinase) to the nucleus, (ii) the inaccessibility of native chromatin and (iii) the efficiency of mammalian repair systems. The last problem might be solved by application of novel reactive groups that produce interstrand crosslinks more efficiently.
